Showing results (831-840 of 850) with videos related to
Sort By:
Pageof 85
Haematologica|November 27, 2025
Cell-free BRAF-V600E levels predict progression-free survival in children with Langerhans cell histiocytosis treated with dabrafenib and maintenance chemotherapyLei Cui, Dong Wang, Yun-Ze Zhao, et al.Bioorganic & Medicinal Chemistry Letters|March 24, 2007
Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitorsYounes Bekkali, David S Thomson, Raj Betageri, et al.Archives of Pathology & Laboratory Medicine|May 15, 2024
Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell HistiocytosisChan-Juan Wang, Lei Cui, Shuang-Shuang Li, et al.Scientific Reports|July 11, 2015
Genome-scale long noncoding RNA expression pattern in squamous cell lung cancerYing Wang, Chen-Yue Qian, Xiang-Ping Li, et al.Chemmedchem|February 1, 2021
E7766, a Macrocycle-Bridged Stimulator of Interferon Genes (STING) Agonist with Potent Pan-Genotypic ActivityDae-Shik Kim, Atsushi Endo, Francis G Fang, et al.Evidence-Based Complementary and Alternative Medicine : Ecam|June 6, 2013
The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in PrediabetesXi Li, Feng-Mei Lian, Dong Guo, et al.Journal of Medicinal Chemistry|July 31, 2007
Discovery and optimization of p38 inhibitors via computer-assisted drug designDaniel R Goldberg, Ming-Hong Hao, Kevin C Qian, et al.Journal of Medicinal Chemistry|December 3, 2002
Design and synthesis of dipeptide nitriles as reversible and potent Cathepsin S inhibitorsYancey D Ward, David S Thomson, Leah L Frye, et al.Molecular Cancer Therapeutics|June 1, 2022
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast CancerCraig Furman, Xiaoling Puyang, Zhaojie Zhang, et al.Bioorganic & Medicinal Chemistry Letters|September 1, 2009
The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part IIJiang-Ping Wu, Roman Fleck, Janice Brickwood, et al.Pageof 85